Updates

Date: 21st August, 2026 To To The Listing Department The Listing Department National Stock Exchange of India Limited Bombay Stock Exchange Limited Exchange Plaza, Floor 25, P. J. Towers, Bandra – Kurla Complex Dalal Street, Bandra (East) Mumbai – 400 001 Mumbai – 400 051 Stock Code : 532612 Stock Code : INDOCO Dear Sir/Madam, Sub: Business Responsibility and Sustainability Report for the financial year 2025-2026 Pursuant to Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith business responsibility and sustainability report for the financial year 2025- 2026. Additionally, the business responsibility and sustainability report is also being uploaded on the website of the Company at www.indoco.com. This is for your information and records. Thanking you, Yours faithfully, For Indoco Remedies Limited Ramanathan Hariharan Company Secretary & Head- Legal BUSINESS RESPONSIBILITY & SUSTAINABILITY REPORT SECTION A: GENERAL DISCLOSURES I. Details of the listed entity 1. Corporate Identity Number (CIN) of L85190MH1947PLC005913 the Listed Entity 2. Name of the Listed Entity Indoco Remedies Limited 3. Year of incorporation 1947 4. Registered office address Indoco House, 166 CST Road, Vidyanagari Marg, Kalina, Santacruz East, Mumbai 400098 5. Corporate address Indoco House, 166 CST Road, Vidyanagari Marg, Kalina, Santacruz East, Mumbai 400098 6. E-mail compliance.officer@indoco.com 7. Telephone +91 22 6287 1000 / 6879 1250 8. Website www.indoco.com 9. Financial year for which reporting is April 01, 2025 to March 31, 2026 being done 10. Name of the Stock Exchange(s) BSE Limited and National Stock Exchange of India Limited where shares are listed 11. Paid-up Capital ` 18,46,07,210/- 12. Name and contact details (telephone, Mr. Ramanathan Hariharan, Company Secretary & Head -Legal, email address) of the person who Tel. No. : +91 22 68321400, may be contacted in case of any Email Id: compliance.officer@indoco.com queries on the BRSR report 13. Reporting boundary Standalone Basis 14. Name of assessment or assurance Not Applicable provider 15. Type of assessment or assurance Not Applicable obtained II. Products/services 16. Details of business activities (accounting for 90% of the turnover): S. No. Description of Main Activity Description of Business Activity % of Turnover of the entity 1 Manufacture of Formulation Manufacturing and Sales of Formulation 100 Pharmaceuticals Pharmaceuticals 17. Products/Services sold by the entity (accounting for 90% of the entity’s turnover): S. Product/Service NIC Code % of total Turnover No. contributed 1 Formulation Pharmaceutical Preparation 21002 89 2 Chemical Preparation (Active Pharma Ingredients) 21001 9 3 Analytical Research & Bio-Equivalent Studies 72100 2 ANNUAL REPORT 2025 - 2026 118 III. Operations 18. The number of locations where plants and/or operations/offices of the entity are situated: Location Number of plants Number of offices Total National 8 4 12 International Nil 1 1 19. Markets served by the entity: a. Number of locations Locations Number National (No. of States) 20 International (No. of Countries) 55+ b. What is the contribution of exports as a percentage of the total turnover? 45.10 % of the Company’s total revenue (standalone) can be attributed to its earnings from exports. c. A brief on types of customers Indoco, being a Pharmaceutical Company, has a diverse customer base that includes patients, healthcare professionals/providers, hospitals, clinics, wholesalers, distributors, retail pharmacies, government agencies/institution, other pharmaceutical companies and international customers. The end-users of Indoco’s products are patients who rely on its medicines to treat various ailments. The Company exports its products to various countries worldwide, catering to a global customer base. IV. Employees 20. Details as at the end of the Financial Year: a. Employees and workers (including differently abled): S. Particulars Total (A) Male Female No. (B) % (B / A) No. (C) % (C / A) Employees 1. Permanent (D) 5,036 4,591 91.16 445 8.84 2. Other than Permanent (E) 2 1 50 1 50 3. Total employees (D + E) 5,038 4,592 91.15 446 8.85 Workers 4. Permanent (F) 708 684 96.61 24 3.39 5. Other than Permanent (G) 809 688 85.04 121 14.96 6. Total workers (F + G) 1,517 1,372 90.44 145 9.56 Note: The figures for the Previous Financial Year 2024-2025 and Current Financial Year 2025-2026 are not directly comparable, as the Current Financial Year includes headcount for Other than Permanent Workers. This change has been made to improve the accuracy and transparency of our sustainability reporting. b. Differently abled Employees and workers: S. Particulars Total (A) Male Female No. (B) % (B / A) No. (C) % (C / A) Differently-abled employees 1. Permanent (D) 1 1 100 Nil Nil 2. Other than Permanent (E) Nil Nil Nil Nil Nil Total differently abled 3. 1 1 100 Nil Nil employees (D + E) Differently-abled workers 4. Permanent (F) Nil Nil Nil Nil Nil 5. Other than Permanent (G) Nil Nil Nil Nil Nil Total differently abled 6. Nil Nil Nil Nil Nil workers (F + G) 21. Participation/Inclusion/Representation of women Particulars Total (A) No. and percentage of Females No. (B) % (B / A) Board of Directors 8 2 25 Key Management Personnel 2 Nil Nil 22. The turnover rate for permanent employees and workers Particulars FY 2025-26 FY 2024-25 FY 2023-24 Male Female Total Male Female Total Male Female Total Permanent Employees 35.82% 26.20% 35.07% 48.70% 26.17% 46.74% 47.13% 23.79% 45.07% Permanent Workers 21.74% 11.11% 21.42% 27.93% 23.08% 27.70% 27.05% 50.00% 28.16% V. Holding, Subsidiary and Associate Companies (including joint ventures) 23. (a) Names of holding / subsidiary / associate companies / joint ventures S. Name of the holding / subsidiary / associate Indicate whether % of shares Does the entity indicated at No. companies / joint ventures (A) Holding / Subsidiary / held by listed column A, participate in the Associate / Joint entity Business Responsibility Venture initiatives of the listed entity? (Yes/No) 1 Xtend Industrial Designers and Subsidiary 100 No Engineers Private Limited 2 Indoco Remedies Czech S.R.O. Subsidiary 100 No 3 Indoco Remedies UK Limited Subsidiary 100 No 4 Warren Remedies Private Limited Subsidiary 100 No 5 FPP Holding Company, LLC Subsidiary 85 No 6 Jalansar Wind Energy Private Limited Associate 26 No 7 Kanakal Wind Energy Private Limited Associate 26 No ANNUAL REPORT 2025 - 2026 120 VI. CSR Details 24. (i) Whether CSR is applicable as per section 135 of Companies Act, 2013: Yes (ii) Turnover (`) : ` 1,63,353.81 Lakhs (iii) Net worth (`) : ` 1,09,277.23 Lakhs VII. Transparency and Disclosures Compliances 25. Complaints/Grievances on any of the principles (Principles 1 to 9) under the National Guidelines on Responsible Business Conduct: Stakeholder Grievance Redressal Mechanism in Place FY 2025-26 FY 2024-25 group from (Yes/No) whom complaint (If Yes, then provide web-link for grievance Number of Number of Remarks Number of Number of Remarks is received redress policy) complaints complaints complaints complaints filed pending filed pending during the resolution during the resolution year at close of year at close of the year the year https://www.indoco.com/ Communities Nil Nil N.A. Nil Nil N.A. policies/grievance_redressal_ policy_external.pdf Investors https://www.indoco.com/ (other than Nil Nil N.A. Nil Nil N.A. policies/grievance_redressal_ shareholders) policy_external.pdf Shareholders https://www.indoco.com/inv- Nil Nil N.A. Nil Nil N.A. grievances.asp https://www.indoco.com/ policies/policy-on-prevention- of-sexual-harassment-at-the- workplace.pdf Employees Nil Nil N.A. Nil Nil N.A. and workers https://www.indoco.com/ policies/code_of_conduct.pdf https://www.indoco.com/ policies/Whistle_Blower_and_ Vigil_Mechanism.pdf https://www.indoco.com/contact- The pend- pending us.asp ing Com- Com- plaints Customers 205 17 84 4 plaints are under https [Showing first 8,000 characters — download PDF for full document]